Cleared Special

K160365 - BLE Smart Blood Glucose Monitoring System

K160365 is the FDA 510(k) clearance for BLE Smart Blood Glucose Monitoring System by Infopia Co, Ltd.. It is a Class 2 Chemistry device (product code NBW) cleared through the Special 510(k) pathway after a 232-day FDA review.

K160365 · Infopia Co, Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2016
Decision
232d
Days
Class 2
Risk

K160365 is an FDA 510(k) clearance for the BLE Smart Blood Glucose Monitoring System, BLE Smart Professional Blood Gluco.... Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Infopia Co, Ltd. (Anyang, KR). The FDA issued a Cleared decision on September 28, 2016 after a review of 232 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Infopia Co, Ltd. devices

Submission Details

510(k) Number K160365 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 09, 2016
Decision Date September 28, 2016
Days to Decision 232 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
144d slower than avg
Panel avg: 88d · This submission: 232d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 236
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K160365.
AG-607 Blood Glucose Monitoring System and AG-607 Multi Blood Glucose Monitoring System
K153561 · Andon Health Co, Ltd. · Feb 2017
BGM014 Blood Glucose Monitoring System, BGM014 Pro Blood Glucose Monitoring System
K161299 · Apex BioTechnology Corp. · Dec 2016
FORA ADVANCED GD40 and FORA ADVANCED GD40 pro Blood Glucose and ß-Ketone Monitoring Systems
K161738 · Taidoc Technology Corporation · Nov 2016
Wireless Smart Gluco-Monitoring System
K153278 · Andon Health Co, Ltd. · Aug 2016
iHealth Align Gluco-Monitoring system
K153286 · Andon Health Co, Ltd. · Aug 2016
StatStrip Xpress Blood Glucose Monitoring System
K160156 · Nova Biomedical Corporation · Jun 2016